Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread

被引:95
作者
Bando, H
Matsumoto, G
Bando, M
Muta, M
Ogawa, T
Funata, N
Nishihira, J
Koike, M
Toi, M
机构
[1] Tokyo Metropolitan Komagome Hosp, Breast Unit, Bunkyo Ku, Tokyo 1130021, Japan
[2] Tokyo Metropolitan Komagome Hosp, Dept Pathol, Bunkyo Ku, Tokyo 1130021, Japan
[3] Hokkaido Univ, Sch Med, Cent Res Inst, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[4] Tokyo Med & Dent Univ, Dept Pathol, Bunkyo Ku, Tokyo 1138519, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 2002年 / 93卷 / 04期
关键词
MIF; nodal spread; breast cancer; tumor marker; angiogenesis;
D O I
10.1111/j.1349-7006.2002.tb01269.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Macrophage migration inhibitory factor (MIF) is known to exert pleiotropic functions including inhibition of macrophage migration, anchoring, and counteraction of the anti-inflammatory and immunosuppressive activity of glucocorticoids. Ninety-three primary breast cancer tissues and 64 sera of primary breast cancer patients were analyzed for the expression of MIF. The clinico-pathological significance of MIF expression was evaluated. It was found that MIF was frequently over-expressed in primary breast cancer tissues. RT-PCR and western blotting analysis confirmed that wild-type MIF is expressed, and immunohistochemical analysis showed that MIF expression was localized at tumor cells as well as stromal cells, including tumor-associated macrophages. Intratumoral MIF protein concentrations detected by enzyme-linked immunosorbent assay (ELISA) varied with a median value of 1821 ng/mg protein (range: 8-8126 ng/mg protein), and correlated inversely with nodal involvement (P=0.039). No significant correlation was observed with other clinico-pathological factors including tumor size, menopausal status and hormone receptors. The circulating level of MIF protein ranged up to 105.7 ng/ml (median: 17.3 ng/ml), and it was also found to correlate inversely with the number of involved nodes (P=0.02). A comparative study with other soluble inflammatory mediators showed that intratumoral levels of MIF were significantly associated with those of interleukin-1beta, suggesting that interactions between tumor cells and tumor-associated macrophages play an important role in the up-regulation of MIF. The multifunctional inflammatory/immune mediator MIF was frequently expressed in primary breast cancer, and its expression level was inversely associated with nodal spread. Thus, MIF seems to play a role in tumor-stroma interactions of primary breast cancers, particularly those with a phenotype of node-negative or minimal nodal spread.
引用
收藏
页码:389 / 396
页数:8
相关论文
共 42 条
[1]   Regulation of the CTL response by macrophage migration inhibitory factor [J].
Abe, R ;
Peng, T ;
Sailors, J ;
Bucala, R ;
Metz, CN .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :747-753
[2]  
Apte RS, 1998, J IMMUNOL, V160, P5693
[3]   An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].
Bacher, M ;
Metz, CN ;
Calandra, T ;
Mayer, K ;
Chesney, J ;
Lohoff, M ;
Gemsa, D ;
Donnelly, T ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854
[4]   The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle [J].
Benigni, F ;
Atsumi, T ;
Calandra, T ;
Metz, C ;
Echtenacher, B ;
Peng, T ;
Bucala, R .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) :1291-1300
[5]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[6]   PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[7]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[8]   MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response [J].
Bucala, R .
FASEB JOURNAL, 1996, 10 (14) :1607-1613
[9]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[10]   Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria [J].
Calandra, T ;
Spiegel, LA ;
Metz, CN ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11383-11388